Dr. Gucalp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MMC Dept of Oncology
111 East 210TH Street
Bronx, NY 10467Phone+1 718-405-8536Fax+1 718-798-7474
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1986 - 1990
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1982 - 1984
Hacettepe University FOMClass of 1975
Certifications & Licensure
NY State Medical License 1992 - 2026
TX State Medical License 1992 - 1993- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Start of enrollment: 1988 Apr 01
- BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma Start of enrollment: 2002 Jan 01
- Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer Start of enrollment: 2004 May 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsHIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management.Ayse Ece Cali Daylan, Catarina Martins Maia, Shirin Attarian, Xiaoling Guo, Mindy Ginsberg
Clinical Lung Cancer. 2024-03-01 - 4 citationsSelective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).Nitin Ohri, Shruti Jolly, Benjamin T Cooper, Rafi Kabarriti, William R Bodner
Journal of Clinical Oncology. 2024-02-10 - 1 citationsExploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer.Michael Pennock, Balazs Halmos, William Bodner, Haiying Cheng, Rasim Gucalp
Clinical and Translational Radiation Oncology. 2023-07-01
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
